Skip to main content
. 2007 Aug 8;81(20):11341–11351. doi: 10.1128/JVI.00930-07

TABLE 3.

Numbers and distributions of nucleotide and amino acid substitutions observed in the O Tw97 genome consensus sequence during passages in vivo and in vitroa

Passage group No. (%) of substitutions for indicated regionb
Lpro
P1
P2
P3
VP4
VP3
VP2
VP1
2A
2B
2C
3A
3B
3C
3D
nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa
In vivo 6 (16) 1 (11) 0 0 1 (3) 0 5 (13) 1 (11) 2 (5) 0 0 0 2 (5) 1 (11) 10 (27) 3 (33) 1 (3) 0 0 0 4 (11) 1 (11) 6 (16) 2 (22)
In vitro 3 (15) 2 (12) 1 (5) 1 (6) 1 (5) 1 (6) 1 (5) 1 (6) 4 (20) 4 (25) 0 0 1 (5) 0 1 (5) 1 (6) 1 (5) 1 (6) 1 (5) 1 (6) 1 (5) 1 (6) 5 (24) 3 (19)
a

The total numbers of substitutions were 48 in vivo and 22 in vitro. Total numbers (percentages) of substitutions for subgroups are as follows: for UTRs in vivo, 11 (23); for ORFs in vivo, 37 (77); for UTRs in vitro, 2 (9); for ORFs in vitro, 20 (91); for nucleotides in P1 in vivo, 8 (22); for amino acids in P1 in vivo, 1 (11); for nucleotides in P2 in vivo, 12 (32); for amino acids in P2 in vivo, 4 (44); for nucleotides in P3 in vivo, 11 (30); for amino acids in P3 in vivo, 3 (33); for nucleotides in P1 in vitro, 7 (35); for amino acids in P1 in vitro, 7 (44); for nucleotides in P2 in vitro, 2 (20); for amino acids in P2 in vitro, 1 (6); for nucleotides in P3 in vitro, 8 (40); for amino acids in P3 in vitro, 6 (37).

b

nt, nucleotide; aa, amino acid.